# Shenzhen Shenxin Biotechnology Co., Ltd.

> Reevol Source machine-readable supplier card. Profile URL: https://source.reevol.com/en/suppliers/shenzhen-shenxin-biotechnology/. Locale: en.

## Identity
- Legal name (en): Shenzhen Shenxin Biotechnology Co., Ltd.
- Legal name (zh-CN): 深圳深信生物科技有限公司
- Aliases: 深圳深信生物科技有限公司
- Business type: unknown
- Location: Hong Kong, Hong Kong
- Year founded: 2019
- Employee range: 12

## Industry
- Primary: Pharmaceuticals
- Sub-industries: mRNA, liposome, delivery, vaccine, cancer immunotherapy, chronic disease
- HS codes: 3002, 3001, 2941

## Digital footprint
- LinkedIn: http://www.linkedin.com/company/innorna
- Visibility score (0-100): 0

## Summary
What we know: Founded in 2019, based in Hong Kong (verified by year founded and country) Team of 12 focused on mRNA, liposome delivery, vaccines, and cancer immunotherapy (verified by team size and industry tags) HS codes 3002, 3001, 2941 align with blood fractions, glands/organs, and antibiotics (verified by HS codes)

What the data suggests: Early-stage biotech supplier; limited public footprint suggests pre-commercialization or early market entry (suggested by year founded and team size) Therapeutic focus spans vaccines and chronic disease, indicating potential for both public health and commercial markets (suggested by industry tags)

Not yet verified: Website, Certifications, Trade fairs, Export markets, Production capacity.

Verify Shenzhen Shenxin Biotechnology before reaching out - Reevol returns a verification brief within 24 hours.

## Provenance
- Last enriched: 2026-04-06T10:25:24.425Z
- AI content last generated: 2026-06-01T18:11:46.351Z
- Source: Reevol Source (https://source.reevol.com). Underlying data from Reevol, sourced from public business registries, trade-fair exhibitor lists, certification bodies, and digital footprint.
- License: see https://source.reevol.com/en/methodology/
